Turmeric Beat Placebo by 0.72 Points on Knee Pain
Small trials found little improvement in pain, movement or quality of life compared with placebo. For people with knee osteoarthritis, established guidance puts exercise first.
Turmeric supplements may offer little or no meaningful relief for knee osteoarthritis, a Cochrane review has found, weakening the case for pills promoted for painful joints. [2]
The review, published on November 19, 2026, brought together nine studies involving 1,245 people. Its strongest test of whether turmeric itself helped came from four studies that compared the supplements with placebo, involving 379 participants. [2]
On a pain scale running from zero to 10, turmeric produced an average improvement just 0.72 points greater than placebo. The differences in physical function and quality of life were also small. Cochrane concluded that the supplements may make little to no improvement in these outcomes. [2]
Osteoarthritis is a long-term joint disease that can cause pain, stiffness and difficulty moving. Turmeric supplements are often promoted as an alternative therapy for joint problems, making the question practical for anyone deciding whether another bottle belongs in the shopping basket. [2][1]
Cochrane rated the evidence for benefits as "low certainty". The findings weaken the case for buying turmeric to manage arthritic knees, while leaving room for better research to change the estimates. [2]
What the numbers show
People taking turmeric reported an average pain reduction of 2.29 points on the 10-point scale. Those taking placebo reported a reduction of 1.57 points. The pooled pain calculation used data from 349 participants across the four placebo-controlled studies. [2]
The improvement within the turmeric group can sound encouraging on its own. But the useful measure is the extra improvement over the comparison group: less than one point. Counting the entire reduction as a turmeric benefit would give the supplement credit for improvement that also occurred among people taking placebo.
For physical function, turmeric was associated with an additional 3.5 points of improvement on a scale from zero to 100. That calculation drew on 348 participants in four studies. For quality of life, the additional improvement was 2.19 points on a 100-point scale, based on 291 participants in three studies. [2]
These scales turn patients' experiences into numbers that researchers can compare. A difference can favour a treatment numerically without adding up to useful relief in daily life. Cochrane's assessment was that the measured gains may amount to little or no benefit. [2]
One result was more encouraging. In two studies involving 170 participants, more people rated treatment successful when taking turmeric. The estimated difference was 84 additional people per 1,000, equivalent to about eight additional people in every 100. Cochrane also rated this evidence as low certainty. [2]
That result captures patients' overall judgement of treatment, alongside the separate measurements of pain, function and quality of life. It gives researchers something to investigate, but it is too uncertain to carry a confident recommendation.
The headline total of 1,245 participants should therefore not be mistaken for the size of the placebo test. Four of the other studies compared turmeric with anti-inflammatory pain medicines, and one compared it with paracetamol. Those comparisons ask different questions from whether turmeric helps more than placebo. [2]
Short trials, different pills
Ivan Shirinsky and colleagues, the review's authors, examined trials lasting from four weeks to three months. They took place in Australia, Belgium, India and Thailand. Participants' average ages ranged from 52 to 62, and about two-thirds were women. [2]
The studies tested different turmeric supplements, with differing doses and formulations of curcumin, a constituent of turmeric. Pooling them provides a broader assessment of the supplements tested, rather than a verdict on one uniform product. [2][1]
The review cannot settle whether a particular standardized formulation works, whether benefits persist beyond three months, or whether results differ for hip or hand osteoarthritis. Safety is also unresolved: Cochrane said it was very uncertain whether turmeric affected unwanted events, serious unwanted events or withdrawals because of unwanted events. [2]
A short trial of a supplement is a poor foundation for confidence about taking it indefinitely. The uncertainty about harms gives no reason to treat turmeric as a risk-free fallback.
The researchers searched for studies through November 7, 2025, using seven databases and two trial registers. They also applied a screening tool to assess study trustworthiness. Cochrane reported that the review received no external funding. [2]
A systematic review can assemble and assess the research carefully. It cannot make small, short studies answer questions they were not built to answer.
What to do for painful knees
The practical alternative to turmeric is an active treatment plan. NICE, the UK's National Institute for Health and Care Excellence, recommends tailored therapeutic exercise for everyone with osteoarthritis. [3]
For people living with overweight or obesity, the guideline recommends support with weight loss. These are core parts of managing the condition, rather than optional extras after a medicine has been chosen. [3]
When medication is needed for knee osteoarthritis, NICE says to offer a topical non-steroidal anti-inflammatory drug, a medicine applied to the skin over the joint. [3]
If topical medicines are ineffective or unsuitable, an oral anti-inflammatory drug may be considered after accounting for potential risks. NICE also recommends gastroprotective treatment, medicine to help protect the stomach, while someone takes an oral anti-inflammatory. [3]
Those recommendations come from a clinical guideline. This turmeric review did not test exercise, weight management or topical medicines head-to-head against the supplements. [2][3]
For the next round of turmeric research, Shirinsky and colleagues recommend studies lasting longer than three months and including people with hand and hip osteoarthritis. A useful trial will need to show that a clearly defined product delivers relief patients notice, and measure the unwanted effects of taking it for longer. [2]
Every edition in brief, three times a day, on our Telegram channel, on Bluesky and on Threads.
Spotted an error? Tell the editors
- Turmeric supplements offer little benefit for knee osteoarthritis | New Scientist New Scientist
- What are the benefits and risks of turmeric (Curcuma longa) supplements for people with osteoarthritis? | Cochrane cochrane.org
- Recommendations | Osteoarthritis in over 16s: diagnosis and management | Guidance | NICE nice.org.uk




